• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 90 of 95
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By The Associated PressJanuary 29, 2021
Pascal Soriot, chief executive officer of AstraZeneca Plc, listens during a Senate Finance Committee hearing on drug pricing on Capitol Hill in Washington, D.C., U.S., on Tuesday, Feb. 26, 2019.
Health
Germany may not use AstraZeneca’s vaccine for over-65s, as experts debate lack of data
By Jeremy Kahn and David MeyerJanuary 28, 2021
Valneva-Covid19 Vaccine
Health
France’s Valneva starts making COVID-19 vaccine in Scotland, ahead of trial results and approval
By David MeyerJanuary 28, 2021
State-by-state COVID vaccine rates: Idaho and Missouri are in last place
Health
State-by-state COVID vaccine rates: Idaho and Missouri are in last place
By Erika Fry and Nicolas RappJanuary 27, 2021
COVID vaccine second shot, dose
Health
What to know about delaying second COVID vaccine shots as countries grapple with limited supplies
By John Lauerman, Jason Gale and BloombergJanuary 26, 2021
An NHS staff member prepares an AstraZeneca Covid-19 vaccination as over-eighty year olds receive their vaccinations on January 26, 2021 at Stithians Showground, near Truro, England.
Health
Furious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf
By David MeyerJanuary 26, 2021
US-VIRUS-HEALTH-VACCINATION
Health
CEO who jumped the COVID vaccine line is out of a job
By BloombergJanuary 25, 2021
Pharmacist Josh Athwal (left) receives an injection of the Oxford/Astrazeneca coronavirus vaccine, administered by nurse Gurit Dhadday, at The Black Country Living Museum in Dudley.
Health
AstraZeneca is finding it hard to keep its COVID-19 vaccine promises
By David MeyerJanuary 25, 2021
ISRAEL-HEALTH-VIRUS
Health
Israel is leading the world in COVID vaccinations—and its cases and hospitalizations are starting to decline
By Ivan Levingston and BloombergJanuary 24, 2021
COVID pandemic status
Health
5 statistics to know about where the COVID pandemic stands in the U.S.
By Sy Mukherjee and Nicolas RappJanuary 23, 2021
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
Health
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
By Bernhard Warner and David MeyerJanuary 22, 2021
Why the COVID vaccine rollout is a massive tech challenge
Tech
Why the COVID vaccine rollout is a massive tech challenge
By Fortune EditorsJanuary 22, 2021
Carnival cancels more cruises and Bond flick postponed again in latest signs of tough COVID-19 slog
Health
Carnival cancels more cruises and Bond flick postponed again in latest signs of tough COVID-19 slog
By Phil WahbaJanuary 22, 2021
How to accelerate the far-too-slow COVID vaccine rollout
Commentary
How to accelerate the far-too-slow COVID vaccine rollout
By Oliver KharrazJanuary 21, 2021
Biden’s not done signing executive orders—here’s his agenda for the next 9 days
Politics
Biden’s not done signing executive orders—here’s his agenda for the next 9 days
By Aric JenkinsJanuary 21, 2021
1...
  • 88
  • 89
  • 90
  • 91
  • 92
...95
Most Popular
Economy
D.C.'s affordability headache has a silver bullet, new study shows: Tackling $40 trillion national debt would boost household income by $36,000placeholder alt text
By Eleanor PringleSeptember 23, 2026
Personal Finance
After 40 investors rejected Jeff Bezos’ Amazon pitch, his parents offered $245,573 of their retirement savingsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 22, 2026
Personal Finance
Multimillionaire author Bill Perkins says parents should give kids their inheritance in their 20s when it can transform their lives—not when they dieplaceholder alt text
By Marco Quiroz-GutierrezSeptember 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.